🔥 Fat Loss Peptides
Lose fat faster.
The science
is here.
GLP-1 agonists, growth hormone peptides, and metabolic compounds — research-grade, third-party tested, shipped discreetly across Canada.
19
Compounds
99%+
Purity
2–4 days
Delivery
The Process
How fat loss peptides work
Unlike stimulants or crash diets, peptides work with your body's own metabolic systems — targeting appetite, fat oxidation, and hormonal regulation at the cellular level.
01
Appetite Regulation
GLP-1 agonists like Semaglutide and Retatrutide signal the hypothalamus to reduce hunger — you eat less without willpower battles.
02
Fat Oxidation
Growth hormone peptides like Tesamorelin stimulate lipolysis — the direct breakdown of stored fat for energy, especially visceral fat.
03
Metabolic Rate
Peptides like CJC-1295 elevate baseline growth hormone, increasing resting metabolic rate and preserving lean muscle during a deficit.
04
Sustained Results
Unlike stimulants, peptides don't cause rebound. They reset metabolic set points, making it easier to maintain results long-term.
The Science
GLP-1: the most studied fat loss mechanism in history
Glucagon-like peptide-1 (GLP-1) is a naturally occurring incretin hormone. When activated by peptide agonists, it produces clinically validated fat loss that no supplement can replicate.
Dual and triple agonism
Retatrutide activates GLP-1, GIP, and glucagon receptors simultaneously — the most potent fat loss mechanism available outside a clinical trial.
Visceral fat reduction
Tesamorelin specifically targets visceral adipose tissue — the dangerous fat around organs — with FDA-approved evidence behind it.
Muscle preservation
Unlike caloric restriction alone, GH peptides preserve lean mass during fat loss — you lose fat, not muscle.
Fat Loss Collection
19 research-grade compounds
Fat Oxidation
Fat Loss · SubQ / Oral
L-Carnitine Injectable
L-Carnitine — essential cofactor for mitochondrial fatty acid transport that increases fat oxidation, improves exercise performance, and supports cardiac energy metabolism.
GLP-1 Agonist
Fat Loss · SubQ
Semaglutide
Semaglutide — GLP-1 receptor agonist that suppresses appetite, slows gastric emptying, and drives sustained fat loss.
Lipotropic Blend
Fat Loss · IM / SubQ
Lipo-C Injectable (Without B12)
Lipo-C — injectable lipotropic compound blend combining L-Carnitine, MIC (Methionine, Inositol, Choline), and B vitamins for synergistic fat mobilisation and hepatic lipid clearance.
Dual Agonist
Fat Loss · SubQ
Tirzepatide
Tirzepatide — dual GIP/GLP-1 agonist that outperforms single-axis GLP-1 therapy for fat loss and metabolic remodelling.
Triple Agonist
Fat Loss · SubQ
Retatrutide
Retatrutide — triple GIP/GLP-1/glucagon agonist with the most potent clinical weight loss signal observed in a peptide therapeutic to date.
Amylin Analogue
Fat Loss · SubQ
Cagrilintide
Cagrilintide — long-acting amylin analogue that reduces food intake via area postrema signalling, independent of and additive to GLP-1 mechanisms.
Somatotropin
Fat Loss · SubQ
HGH (Human Growth Hormone)
HGH — endogenous somatotropin that drives IGF-1 production, promotes lipolysis, stimulates muscle protein synthesis, and supports tissue regeneration.
Lipolytic Fragment
Fat Loss · SubQ
HGH Fragment 176-191
HGH Fragment 176-191 — isolated C-terminal lipolytic domain of human growth hormone that burns fat without stimulating IGF-1 or muscle growth.
Compare
Which fat loss peptide is right for you?
Every compound works differently. Use this guide to match your goals, experience level, and budget.
| Compound | Mechanism | Avg. Fat Loss | Muscle Preservation | Beginner Friendly | Best For | |
|---|---|---|---|---|---|---|
| Semaglutide Gold Standard | GLP-1 agonist | ~15% BW | ✓ | ✓ | First-time users, steady fat loss | View → |
| Retatrutide Most Potent | GLP-1 + GIP + Glucagon | ~24% BW | ✓ | ✗ | Maximum fat loss, experienced users | View → |
| Tirzepatide | GLP-1 + GIP dual agonist | ~20% BW | ✓ | ✗ | Step up from Semaglutide | View → |
| Tesamorelin | GHRH analogue | Visceral fat targeted | ✓✓ | ✓ | Abdominal/visceral fat, lean mass | View → |
Dosing Guide
Recommended protocols
Research-based starting points. Always consult a licensed healthcare provider before beginning any peptide protocol.
Semaglutide
Retatrutide
Tesamorelin
Starting Dose
0.25
mg / week (SubQ)
Maintenance Dose
1–2.4
mg / week
Cycle Length
12–24
weeks
Protocol Notes
Increase dose by 0.25mg every 4 weeks. Inject once weekly into the abdomen, thigh, or upper arm. Most users see significant appetite reduction within 2–4 weeks.
Starting Dose
0.5
mg / week (SubQ)
Maintenance Dose
4–12
mg / week
Cycle Length
16–24
weeks
Protocol Notes
Titrate slowly — Retatrutide is significantly more potent than Semaglutide. Increase by 0.5mg every 4 weeks. Nausea is common in early weeks; take with food and stay hydrated. Not recommended for beginners.
Daily Dose
1–2
mg / day (SubQ)
Injection Timing
AM
fasted, pre-workout
Cycle Length
12–26
weeks
Protocol Notes
Inject daily in the morning, ideally fasted. Tesamorelin specifically targets visceral fat and is best stacked with a GLP-1 agonist for maximum effect. Results are typically visible at 6–8 weeks.
Why it works
Real results, backed by research
These aren't supplements. They're the same class of compounds used in landmark clinical trials — at research-grade purity.
15–20%
Average body weight reduction with GLP-1 protocols
8–12 wks
Typical time to see significant fat loss results
99%+
Purity on every batch — third-party verified
500+
Canadian customers served
Peer-Reviewed Research
Backed by clinical evidence
Every compound in our fat loss catalog has peer-reviewed research supporting its mechanism and efficacy.
1
Semaglutide 2.4mg — 15.3% Weight Reduction
STEP 1 trial: 1,961 adults with obesity. Semaglutide 2.4mg once weekly produced 15.3% mean body weight reduction vs 2.6% placebo at 68 weeks.
New England Journal of Medicine, 2021
Wilding et al. · Read study →
2
Retatrutide — 24.2% Body Weight Reduction
Phase 2 trial: Retatrutide 12mg produced 24.2% mean weight reduction at 48 weeks — the highest ever recorded for a pharmacological weight loss compound.
New England Journal of Medicine, 2023
Jastreboff et al. · Read study →
3
Tesamorelin — FDA-Approved Visceral Fat Reduction
Two Phase 3 trials demonstrated Tesamorelin 2mg/day significantly reduced visceral adipose tissue (VAT) by 15–18% vs placebo at 26 weeks.
Journal of Clinical Endocrinology, 2010
Falutz et al. · Read study →
What You Receive
Research-grade. Every batch.
Every Poptides order is packed with the same precision as a clinical trial — because your results depend on it.
HPLC-Verified Purity
Every batch is tested by an independent Canadian laboratory using High-Performance Liquid Chromatography. 99%+ purity, guaranteed.
Certificate of Analysis Included
Your COA ships with every order. Scan the QR code to verify your specific batch's lab results in real time.
Discreet Canadian Shipping
Plain packaging, no brand markings. Delivered in 2–4 business days to any Canadian address. Tracked and insured.
Canadian-Owned & Operated
We're a Canadian company serving Canadian researchers. No cross-border customs delays, no currency conversion.
Customer Reviews
What Canadians are saying
Real reviews from verified customers across Canada.
★★★★★
"Started Semaglutide 8 weeks ago. Down 14 lbs and the appetite suppression is unreal — I'm just not hungry anymore. Packaging was discreet, arrived in 3 days to Vancouver."
Michael T.
✓ Verified
★★★★★
"Retatrutide is no joke. 3 months in, lost 22 lbs and my visceral fat is visibly down. The Poptides team answered all my questions before I ordered. Will be a repeat customer."
Sarah K.
✓ Verified
★★★★★
"Tesamorelin specifically for belly fat — it works exactly as described. 6 weeks in and my waist is down 3 inches. COA was included, purity checks out. Legit Canadian company."
David R.
✓ Verified
FAQ
Common questions about fat loss peptides
Everything you need to know before starting your protocol.
Are these peptides legal in Canada?
Peptides sold by Poptides are research-grade compounds. In Canada, they are not scheduled substances and are legal to purchase for research purposes. They are not approved by Health Canada for human therapeutic use. Always consult a licensed healthcare provider before use.
How long until I see fat loss results?
Most users report noticeable appetite suppression within 1–2 weeks. Visible fat loss typically begins at 4–6 weeks. Significant body composition changes are most pronounced at 12–16 weeks. Results vary based on diet, activity level, and dosing protocol.
Do I need to inject these peptides?
GLP-1 agonists (Semaglutide, Retatrutide, Tirzepatide) and Tesamorelin are administered subcutaneously (SubQ) — a small needle injected just under the skin, similar to insulin. The process is straightforward and most users are comfortable within the first few injections.
What's the difference between Semaglutide and Retatrutide?
Semaglutide is a single GLP-1 agonist — well-studied, well-tolerated, and ideal for first-time users. Retatrutide is a triple agonist (GLP-1 + GIP + glucagon), significantly more potent, with clinical trials showing ~24% body weight reduction. Retatrutide is recommended for experienced users who have already used GLP-1 compounds.
How is Poptides' purity verified?
Every batch is tested by an independent Canadian laboratory using HPLC (High-Performance Liquid Chromatography). The Certificate of Analysis (COA) for each batch is available on our Science page and ships with every order. We target 99%+ purity on all compounds.
Can I stack fat loss peptides together?
Yes — many experienced researchers stack a GLP-1 agonist (e.g. Semaglutide) with Tesamorelin for both systemic fat loss and targeted visceral fat reduction. BPC-157 is sometimes added for gut health support during GLP-1 protocols. Always start with a single compound before adding stacks.
Ready to start your fat loss protocol?
Research-grade peptides. Discreet Canadian shipping. COA on every batch.
Shop Fat Loss Peptides →